Layoffs at Vedanta Biosciences
- Layoff events
- 3
- verified and sourced
- Roles reported
- At least 24
- events with no figure are not in this number
- Announced between
- Apr 2024 to Jan 2026
- Reported by
- BioSpace and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Vedanta Biosciences: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Vedanta Biosciences |
Vedanta Biosciences confirmed a significant headcount reduction as it concentrated resources on the Phase 3 VE303 program for recurrent C. difficile infection. |
Not known | Not known | Company-wide | ||
| Vedanta Biosciences |
Rumoured
Pipeline setback
Vedanta Biosciences was reported to be laying off 20% of staff after a phase 2 ulcerative-colitis study failed and the company shifted focus to its C. difficile program. |
Not known | 20% | Company-wide |
1 source for Vedanta Biosciences |
|
| Vedanta Biosciences |
Restructuring
Vedanta Biosciences announced a workforce reduction of roughly 24 jobs, including 12 positions in its CMC team, after completing a peak period of manufacturing campaigns. |
24 | Not known | United States |
1 source for Vedanta Biosciences |
Rumoured A named publication reported it. The company has not confirmed it. Published, and marked as rumoured wherever it appears.
Where this comes from
Every cut listed for Vedanta Biosciences was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Vedanta Biosciences? Tell us on our Discord and we will check it.